CenterBook Partners LP Invests $1.47 Million in ICU Medical, Inc. (NASDAQ:ICUI)

CenterBook Partners LP bought a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 9,452 shares of the medical instruments supplier's stock, valued at approximately $1,467,000.

Other hedge funds also recently added to or reduced their stakes in the company. Captrust Financial Advisors increased its holdings in ICU Medical by 54.2% during the 3rd quarter. Captrust Financial Advisors now owns 2,969 shares of the medical instruments supplier's stock valued at $541,000 after acquiring an additional 1,043 shares in the last quarter. State Street Corp increased its stake in shares of ICU Medical by 9.3% during the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock worth $165,384,000 after purchasing an additional 77,506 shares in the last quarter. Jane Street Group LLC raised its position in shares of ICU Medical by 137.5% during the 3rd quarter. Jane Street Group LLC now owns 28,729 shares of the medical instruments supplier's stock worth $5,235,000 after purchasing an additional 16,635 shares during the last quarter. EP Wealth Advisors LLC purchased a new stake in ICU Medical in the 3rd quarter valued at approximately $247,000. Finally, XTX Topco Ltd acquired a new stake in ICU Medical during the 3rd quarter valued at $342,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Friday, April 4th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, ICU Medical has a consensus rating of "Buy" and an average price target of $168.67.

Remove Ads

ICU Medical Trading Down 0.6 %

Shares of ICUI traded down $0.90 during mid-day trading on Tuesday, hitting $139.64. The company had a trading volume of 148,529 shares, compared to its average volume of 263,736. The stock has a market cap of $3.42 billion, a PE ratio of -30.56 and a beta of 0.86. The business's 50-day simple moving average is $147.87 and its 200-day simple moving average is $160.62. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.